Success Stories: In Just 13 Days NIW Status Confirmed for a Postdoctoral Research Associate in Applied Microeconomics, Thanks to NAILG and Premium Processing Upgrade

Client’s Testimonial:

“Thank you so much for your help. I see my case is approved. It is truly exciting to see this. Much grateful for your professional service.”

On February 18^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Associate in the Field of Applied Microeconomics (Approval Notice).

General Field: Applied Microeconomics

Position at the Time of Case Filing: Postdoctoral Research Associate

Country of Origin: Bangladesh

State of Residence at the Time of Filing: Georgia

Approval Notice Date: February 18^th, 2023

Processing Time: 13 days (Premium Processing Requested)

Case Summary:

When a postdoctoral research associate in applied microeconomics came to our firm for his National Interest Waiver application, we knew what route we had to take to lead his case to a certain victory. Our team dug into his academic and professional documents and found the following:

As an expert in the field, his proposed endeavor is to investigate applied microeconomics issues, especially health issues, through a multi-disciplinary perspective using data analysis, empirical skills, and a strong economic lens in order to provide practical solutions for real-world problems related to non-economic phenomena.
This research advancing his proposed endeavor is of evident importance because it addresses the economics of health-related issues, especially pandemics such as COVID-19.
More precisely, his proposed endeavor also has broad implications for the United States since the U.S. both remains a popular country for foreign direct investment (FDI) while also actively investing in other countries across the globe.
This is why one of his 4 recommenders also wrote the following in his petition implying the significance of his work here in the U.S.

“[The client’s] research project involving empirical economics and applied econometrics is extremely important to the United States, as it recommends informs [sic] more sound foreign direct investments. Foreign direct investment is an investment from a company in one country into a country located in another country. [The client’s] research provides valuable information that benefits the United States’ ability to make savvy, informed decisions with regard to foreign direct investment.”

Due to his expertise and record of success, he has come to be considered a leader in the field of applied microeconomics. This is why he has served as a consultant for the World Bank and as a health economist consultant for the Asian Development Bank.
Simultaneously, his research has resulted in 17 peer-reviewed journal articles (1 solo-authored and 4 first-authored) and 2 books.
These publications have been cited a total of 225 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of applied microeconomics.
Additionally, he has pursued research directly related to his proposed endeavor of investigating applied microeconomics issues, especially health issues, through a multi-disciplinary perspective using data analysis, empirical skills, and a strong economic lens for at least 14 years.

Thus, his work experience and expertise spoke of the significance of his research and the value it held for the U.S. economy winning him the approval in just 13 days from the premium processing filing date.

We are proud of having worked with him and we wish him all the best in his future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.